REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Boehringer Ingelheim S A (Colombia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Boehringer Ingelheim S A Profile Updated: September 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Boehringer Ingelheim is a worldwide operating affiliated group of companies with 42,224 employees. The organisation structure has two main business areas: Human Pharmaceuticals and Animal Health.

Headquarters
Cr 11 84A 09 P 5
Bogota D.C.; Bogota D.C; Postal Code: 0806

Contact Details: Purchase the Boehringer Ingelheim S A report to view the information.

Basic Information
Total Employees:
Purchase the Boehringer Ingelheim S A report to view the information.
Outstanding Shares:
Purchase the Boehringer Ingelheim S A report to view the information.
Registered Capital:
Purchase the Boehringer Ingelheim S A report to view the information.
Incorporation Date:
May 31, 1972
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Boehringer Ingelheim S A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
33.48%▲
Total operating revenue
33.5%▲
Operating profit (EBIT)
69.07%▲
EBITDA
61.37%▲
Net Profit (Loss) for the Period
51.14%▲
Total assets
52.62%▲
Total equity
47.83%▲
Operating Profit Margin (ROS)
1.43%▲
Net Profit Margin
0.49%▲
Return on Equity (ROE)
0.7%▲
Debt to Equity Ratio
6.53%▲
Quick Ratio
-0.09%▼
Cash Ratio
-0.11%▼

Similar companies

Droguerias y Farmacias Cruz Verde S.A.S
 
Tecnoquimicas S.A.
Bayer S A
 
Procaps S.A.
Novartis de Colombia S A
 
Merck Sharp & Dohme Colombia S.A.S
Pfizer S A S
 
Sanofi-Aventis de Colombia S.A.
Laboratorios Baxter S.A.
 
Laboratorio Franco Colombiano Lafrancol S.A.S.
Genfar S.A
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo